BioSpace News Archive

GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, announced that management will participate at the following investor conferences in June.

Codexis, Inc., a leading enzyme engineering company, announced the Company will attend the Jefferies Healthcare Conference, being held June 7-9, 2023, in New York, New York.

10x Genomics, Inc., a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities.

Spruce Biosciences, Inc. announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Jefferies Healthcare Conference on June 9, 2023, at 9:30 a.m. ET.

IVERIC bio, Inc. reported that on May 19, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 63 newly-hired, non-executive employees.

GE HealthCare, a leader in breast cancer care technology and diagnostics, has announced that NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent or metastatic breast cancer.

Precision BioSciences, Inc. today announced that the Company will participate in the Stifel Genetic Medicines Day taking place May 30, 2023.

Domus Diagnostics, a U.S.-based point-of-care diagnostics company, has received an award from the National Institutes of Health to further develop its point-of-care nucleic acid amplification and detection test for simultaneous identification of COVID-19, Flu-A, Flu-B, and RSV.

Eterna Therapeutics Inc. today announced the appointment of Megan Yung as Chief Strategy Officer and General Counsel.

Peptilogics, a clinical-stage biotechnology company, today announced top-line interim data of PLG0206 in PJI patients from their ongoing Phase 1b trial.